F

Fulcrum Therapeutics
D

FULC

3.25500
USD
0.28
(9.23%)
مغلق
حجم التداول
22,794
الربح لكل سهم
-0
العائد الربحي
-
P/E
-11
حجم السوق
175,570,342
الأخبار

العنوان: Fulcrum Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.